Tatva Chintan Pharma’s EBITDA climbing 88% year-on-year to ₹32.5 crore from ₹17.3 crore. The company’s EBITDA margin expanded to 19.5% from 14.7% a year earlier.
Tatva Chintan Pharma’s EBITDA climbing 88% year-on-year to ₹32.5 crore from ₹17.3 crore. The company’s EBITDA margin expanded to 19.5% from 14.7% a year earlier.